MedPath

A study comparing Propofol plus fentanyl and Dexmedetomidine for conscious sedation in sclerotherapy patients.

Phase 1
Completed
Conditions
Health Condition 1: D233- Other benign neoplasm of skin of other and unspecified parts of face
Registration Number
CTRI/2019/01/016885
Lead Sponsor
PGIMER CHANDIGARH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
70
Inclusion Criteria

ASA 1

-Age group of 2-12 years

-Scheduled to undergo Sclerotherapy in IR department

Exclusion Criteria

-Acute Respiratory tract infections

-Predicted difficult airway

-History of allergy to propofol, fentanyl or dexmedetomidine

-Patients on sedatives within two weeks prior to surgery

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy of sedation based on intraoperative patient movement scoreTimepoint: Base Line, Before administering bolus, after bolus, Every 2.5 minutes till procedure is over.
Secondary Outcome Measures
NameTimeMethod
Effect on hemodynamics and respiratory depression Ã? Recovery time from sedation <br/ ><br>Ã? Postoperative Pain Score (Visual Analogue Score)Timepoint: Every 2.5 minutes for hemodynmics and resiration <br/ ><br>end of procedure for pain
© Copyright 2025. All Rights Reserved by MedPath